Literature DB >> 25182202

Reviews and prospectives of signaling pathway analysis in idiopathic pulmonary fibrosis.

Zheng Yan, Zhang Kui, Zhu Ping.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing disease with disappointing survival rate, and uneffective therapeutic progress has been made in the last few years, forcing the urgent need to improve research to this disease. The commonly accepted pathogenic hypothesis of IPF is the trigger from continuous alveolar epithelium microinjuries and in the following series events, many signaling pathways were reported to lead to abnormal tissue repair and lung structure derangement in IPF, such as TGF-β, wnt, VEGF and PI3K-Akt signaling pathways. Traditional research of IPF related signaling pathway always focus on the independent function of pathway and disease signals, but the crosstalks and interactions among them were rarely valued. In this review, we summarize the signaling pathways which were reported to play important roles in the pathologic changes of IPF and the synergistic effect among those pathways. Next we discuss the application of genomics research and bioinformatics tools on IPF related pathway analysis, and give a systems biology perspective by integrating multi-level disease related data. The novel prospective of pathway analysis could tease out the complex pathway interaction profiles of IPF, and is powerful to detect IPF related biomarkers for early diagnose and potential therapeutic targets.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genomics research; Idiopathic pulmonary fibrosis; Signaling pathway; Systems biology

Mesh:

Year:  2014        PMID: 25182202     DOI: 10.1016/j.autrev.2014.08.028

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  26 in total

Review 1.  Interstital lung disease in ANCA vasculitis.

Authors:  Marco A Alba; Luis Felipe Flores-Suárez; Ashley G Henderson; Hong Xiao; Peiqi Hu; Patrick H Nachman; Ronald J Falk; J Charles Jennette
Journal:  Autoimmun Rev       Date:  2017-05-04       Impact factor: 9.754

Review 2.  Stem Cells in Lung Injury and Repair.

Authors:  Felicia Chen; Alan Fine
Journal:  Am J Pathol       Date:  2016-08-11       Impact factor: 4.307

Review 3.  Tissue-informed engineering strategies for modeling human pulmonary diseases.

Authors:  Kolene E Bailey; Michael L Floren; Tyler J D'Ovidio; Steven R Lammers; Kurt R Stenmark; Chelsea M Magin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-21       Impact factor: 5.464

Review 4.  The code of non-coding RNAs in lung fibrosis.

Authors:  Huachun Cui; Na Xie; Victor J Thannickal; Gang Liu
Journal:  Cell Mol Life Sci       Date:  2015-05-31       Impact factor: 9.261

Review 5.  Distinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.

Authors:  Juan Shi; Feng Li; Meihui Luo; Jun Wei; Xiaoming Liu
Journal:  Mediators Inflamm       Date:  2017-05-09       Impact factor: 4.711

6.  Active epithelial Hippo signaling in idiopathic pulmonary fibrosis.

Authors:  Jason J Gokey; Anusha Sridharan; Yan Xu; Jenna Green; Gianni Carraro; Barry R Stripp; Anne-Karina T Perl; Jeffrey A Whitsett
Journal:  JCI Insight       Date:  2018-03-22

7.  The identification and validation of hub genes associated with advanced IPF by weighted gene co-expression network analysis.

Authors:  Lingyi Liu; Yanru Yang; Xin Han; Jiwei Hou
Journal:  Funct Integr Genomics       Date:  2022-09-15       Impact factor: 3.674

8.  MicroRNA-27a-3p Is a Negative Regulator of Lung Fibrosis by Targeting Myofibroblast Differentiation.

Authors:  Huachun Cui; Sami Banerjee; Na Xie; Jing Ge; Rui-Ming Liu; Sadis Matalon; Victor J Thannickal; Gang Liu
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

9.  MEG3 is increased in idiopathic pulmonary fibrosis and regulates epithelial cell differentiation.

Authors:  Jason J Gokey; John Snowball; Anusha Sridharan; Joseph P Speth; Katharine E Black; Lida P Hariri; Anne-Karina T Perl; Yan Xu; Jeffrey A Whitsett
Journal:  JCI Insight       Date:  2018-09-06

10.  Network Pharmacology-Based Mechanistic Investigation of Jinshui Huanxian Formula Acting on Idiopathic Pulmonary Fibrosis.

Authors:  Tiantian Liu; Pengli Xu; Shuishui Qi; Shaorui Ke; Qin Hu; Peng Zhao; Jiansheng Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-07       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.